Affimed NV Performance
| AFMDDelisted Stock | USD 0.18 0.04 18.18% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Affimed NV are completely uncorrelated. Affimed NV right now shows a risk of 0.0%. Please confirm Affimed NV daily balance of power and price action indicator , to decide if Affimed NV will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Affimed NV is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Affimed |
Affimed NV Relative Risk vs. Return Landscape
If you would invest 18.00 in Affimed NV on November 3, 2025 and sell it today you would earn a total of 0.00 from holding Affimed NV or generate 0.0% return on investment over 90 days. Affimed NV is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Affimed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Affimed NV Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Affimed NV for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Affimed NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Affimed NV is not yet fully synchronised with the market data | |
| Affimed NV has some characteristics of a very speculative penny stock | |
| Affimed NV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 5.64 M. | |
| Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Affimed NV Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Affimed Stock often depends not only on the future outlook of the current and potential Affimed NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Affimed NV's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.9 M | |
| Cash And Short Term Investments | 72.9 M |
Affimed NV Fundamentals Growth
Affimed Stock prices reflect investors' perceptions of the future prospects and financial health of Affimed NV, and Affimed NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Affimed Stock performance.
| Return On Equity | -1.49 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (87.09) % | |||
| Current Valuation | (12.67 M) | |||
| Shares Outstanding | 16.39 M | |||
| Price To Earning | (2.04) X | |||
| Price To Book | 0.06 X | |||
| Price To Sales | 0.53 X | |||
| Revenue | 8.28 M | |||
| EBITDA | (102.38 M) | |||
| Cash And Equivalents | 237.23 M | |||
| Cash Per Share | 1.59 X | |||
| Total Debt | 19.35 M | |||
| Debt To Equity | 0.1 % | |||
| Book Value Per Share | 1.05 X | |||
| Cash Flow From Operations | (110.27 M) | |||
| Earnings Per Share | (5.09) X | |||
| Total Asset | 97.16 M | |||
| Retained Earnings | (536.13 M) | |||
| Current Asset | 78.33 M | |||
| Current Liabilities | 8.94 M | |||
About Affimed NV Performance
By analyzing Affimed NV's fundamental ratios, stakeholders can gain valuable insights into Affimed NV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Affimed NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Affimed NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.Things to note about Affimed NV performance evaluation
Checking the ongoing alerts about Affimed NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Affimed NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Affimed NV is not yet fully synchronised with the market data | |
| Affimed NV has some characteristics of a very speculative penny stock | |
| Affimed NV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 5.64 M. | |
| Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Affimed NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Affimed NV's stock is overvalued or undervalued compared to its peers.
- Examining Affimed NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Affimed NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Affimed NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Affimed NV's stock. These opinions can provide insight into Affimed NV's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Affimed Stock
If you are still planning to invest in Affimed NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Affimed NV's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |